PRAC1 (Prostate Cancer Susceptibility Candidate 1) is a small nuclear protein located in the nucleoplasm with emerging roles in cancer biology and developmental health. Primary function: PRAC1 serves as a marker of prostate cell identity and is utilized in diagnostic assays to identify cells of prostate origin 12. Mechanism: PRAC1 expression is regulated by DNA methylation patterns, which appear to modulate its transcriptional activity. The gene shows differential methylation in inflammatory contexts, with methylation changes associated with altered expression levels 34. Disease relevance: PRAC1 expression is significantly downregulated in right-sided colorectal cancer compared to left-sided cancer and associates with hypermethylation signatures 5. Additionally, PRAC1 methylation serves as a partial mediator linking prenatal endocrine-disrupting chemical exposure to childhood obesity risk 4. PRAC1 is identified as the most important genomic feature differentiating right- from left-sided colorectal cancer in machine learning models 6. Clinical significance: PRAC1, combined with NKX3-1 and PCA3 markers in RNA in situ hybridization assays, achieves 95% specificity for detecting clinically significant prostate cancer in urine specimens, enabling noninvasive prostate cancer diagnosis 1. These findings suggest PRAC1 has potential utility in cancer diagnostics and may represent a biomarker for disease heterogeneity and developmental health outcomes.